Biodexa Pharmaceuticals Plc (BDRX) stock
Close on Nov 16, 2026Market cap $5.06MP/E –Yield –
How the market prices Biodexa Pharmaceuticals
Each ratio against its own distribution since 2016, from month-end prices and the figures reported at the time
Biodexa Pharmaceuticals trades at 8.8× its earnings, against a median of 67.9× since 2016 — on the cheap side of its own range.
The shaded bar covers the 5th to 95th percentile of month-end values since 2016, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.
Price to sales since 2016
Median 67.9×, today 8.8×
What it earns on the capital it uses
Trailing twelve months over average capital
The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.
What it owes and what covers it
Latest balance sheet, against twelve months of cash generation
Cash and short-term investments exceed every borrowing by £3.23M. That is 539.6% of the £598.58K it would cost to buy the business outright.
Leverage and liquidity
The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.
Scores and rules of thumb
Academic scores computed from the latest two fiscal years. They are screens, not verdicts.
Altman Z-Score
Five ratios that together predicted bankruptcy within two years.
What comes back to shareholders
Trailing twelve months against the market value at the latest close
The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.
How the shares have traded
Total return includes reinvested dividends, to the close on Nov 16, 2026
Relative strength index, 14 days
How much of the recent move has been upward. Extremes are where traders look for a turn.
Total return against the S&P 500
The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.
| Period | BDRX | S&P 500 | Difference | BDRX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +391.1% | -3.1% | +394.2 pts | ||
| 3 months | -81.6% | -4.5% | −77.1 pts | ||
| Year to date | -97.5% | +9.4% | −106.9 pts | ||
| 1 year | -99.0% | +11.3% | −110.3 pts | ||
| 3 years | -100.0% | +70.4% | −170.4 pts | -95.6% | +19.4% |
| 5 years | -100.0% | +68.6% | −168.6 pts | -96.1% | +11.0% |
| 10 years | -100.0% | +297.7% | −397.7 pts | -87.5% | +14.8% |
How much it moves
The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.
Who is betting against it
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M BDRX shares were sold short on Oct 30, 2026, down 99.4% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 37.8% of the volume reported to FINRA was short selling.
The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.
The last twelve reports
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 5,752 | -99.4% | 48,213 | 1.0 |
| Oct 15, 2026 | 919,936 | +4905.1% | 7,171,805 | 1.0 |
| Sep 30, 2026 | 18,380 | -93.2% | 722,370 | 1.0 |
| Sep 15, 2026 | 271,866 | +715.0% | 20,006,870 | 1.0 |
| Aug 31, 2026 | 33,356 | +593.2% | 1,671,352 | 1.0 |
| Aug 14, 2026 | 4,812 | -80.6% | 118,901 | 1.0 |
| Jul 31, 2026 | 24,819 | +150.0% | 319,914 | 1.0 |
| Jul 15, 2026 | 9,927 | -85.3% | 18,424 | 1.0 |
| Jun 30, 2026 | 67,330 | +759.2% | 399,320 | 1.0 |
| Jun 15, 2026 | 7,836 | -22.7% | 27,011 | 1.0 |
| May 29, 2026 | 10,140 | -51.5% | 16,983 | 1.0 |
| May 15, 2026 | 20,907 | +22.3% | 1,633,633 | 1.0 |
Every measure, in full
48 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- –
Valuation ratiosIndustry
Share statisticsIndustry
- Shares Change (YoY)
- 1007.7%
- –
- Float
- 225.82B
- –
- Shares Held by Insiders
- 0.00%
- –
- Shares Held by Institutions
- 0.00%
- –
Short sellingIndustry
- Short Interest
- 5,752
- –
- Short Interest Change
- -99.4%
- –
- Days to Cover
- 1.00
- –
Stock price statisticsIndustry
- Price Change (1 Week)
- -8.94%
- –
- Price Change (1 Month)
- 391.1%
- –
- Price Change (3 Months)
- -79.9%
- –
- Price Change (6 Months)
- -91.1%
- –
- Price Change (YTD)
- -97.5%
- –
- Price Change (1 Year)
- -98.9%
- –
- Price Change (3 Years)
- -100.0%
- –
- Price Change (5 Years)
- -100.0%
- –
- Price Change (10 Years)
- -100.0%
- –
- Average Volume (10 Days)
- 15,576
- –
- Average Volume (20 Days)
- 28,143
- –
- Average Volume (90 Days)
- 1M
- –
- Relative Volume
- 0.01
- –
- Relative Strength Index (14)
- 45.5
- –
- Volatility (1 Year)
- 2635.3%
- –
Returns on capitalIndustry
- Return on Capital Employed (ROCE)
- -86.9%
- –
Financial positionIndustry
- Current Ratio
- 2.41
- –
- Quick Ratio
- 2.22
- –
- Interest Coverage
- -37.75
- –
EfficiencyIndustry
- Employee Count
- 12
- –
Income statement (TTM)Industry
- Pretax Income
- -£6.49M
- –
Balance sheetIndustry
- Net Cash (Debt)
- £3.23M
- –
- Net Cash Per Share
- 0.00 GBP
- –
- Working Capital
- £3.91M
- –
Cash flow (TTM)Industry
- Capital Expenditures
- -£2.00K
- –
- FCF Per Share
- -0.00 GBP
- –
Dividends and yieldsIndustry
- FCF Yield
- -146.1%
- –
- Buyback Yield
- -359.1%
- –
- Shareholder Yield
- -359.1%
- –
Taxes and interestIndustry
- Interest Expense
- £229.00K
- –
- Income Tax
- -£105.00K
- –
Scores and fair valueIndustry
- Altman Z-Score
- -18.48
- –
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?